SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Director/PDMR Shareholding

30 Jun 2025 12:30

RNS Number : 0073P
Accsys Technologies PLC
30 June 2025
 

Accsys Technologies PLC (the "Company")

Director/PDMR Grant of Share Awards under the Accsys Deferred Bonus Plan and under the Accsys Long Term Incentive Plan and Issue of Shares

The Company announces that following recommendation from its Remuneration Committee, on 27 June 2025 (the "Grant Date") it granted awards over 2,248,645 ordinary shares of €0.05 each in the Company ("Shares") under its Deferred Bonus Plan ("DBP") and granted nil cost options over 1,883,769 Shares under its 2025 Long Term Incentive Plan ("LTIP") to certain employees and the Company's Executive Directors, Jelena Arsic van Os and Sameet Vohra, as further set out below.

Deferred Bonus Plan

Awards under the DBP have been granted in respect of bonuses earned for the financial year ending 31 March 2025 over a total of 2,248,645 Shares (the "Bonus Shares"), including to the Executive Directors in such numbers as set out below. The awards to Executive Directors vest 80% on the Grant Date and 20% on the second anniversary of the Grant Date, subject in each case to the sale of such number of Bonus Shares as is required to cover each Director's respective tax and social security liabilities.

Director

Role

Number of Bonus Shares awarded

Number of Bonus Shares vesting on Grant Date

Number of Bonus Shares vesting on second anniversary of Grant Date

Jelena Arsic van Os

Chief Executive Officer

526,435

421,148

105,287

Sameet Vohra

Chief Financial Officer

178,853

143,082

35,771

 

Long Term Incentive Plan 2025 Awards

Awards of nil cost options under the LTIP have been granted over a total of 1,883,769 Shares to various senior employees, including to the Executive Directors in such numbers as are set out below, in accordance with the terms of the LTIP Rules.

The nil cost options are expected to vest three years after grant, subject to the terms of the LTIP Rules, including continued employment of the beneficiaries by the Company and satisfaction of financial and non-financial performance conditions. Details of the performance conditions will be included in the FY26 Annual Report. A two-year holding period applies following the end of the performance period for Executive Directors only.

 

 

 

Director

Role

Number of nil cost options over Ordinary Shares awarded

Jelena Arsic van Os

Chief Executive Officer

778,693

Sameet Vohra

Chief Financial Officer

425,432

 

Following the awards made under the DBP, Jelena Arsic van Os is now beneficially interested in 509,398 Shares and Sameet Vohra is now beneficially interested in 143,082 Shares.

New Share Issues

 

In satisfaction of the grant of awards under the DBP as announced above, the Company further announces the issue of 2,248,645 Bonus Shares to the Company's Employee Benefit Trust ("EBT"), the beneficiaries of which include employees and the Executive Directors.

Application for admission of the Bonus Shares to trading on AIM and Euronext Amsterdam has now been made, with admission expected on or around 3 July 2025. The Company does not hold any shares in treasury. Therefore, the total voting rights in the Company following the issue of the Bonus Shares will be 242,694,212. Following the issue of the Bonus Shares, this figure may be used by shareholders as the denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company's securities under the FCA's Disclosure Guidance and Transparency Rules.

The Company shall make a further announcement once the sale of Shares, as is required to cover each Executive Director's respective tax and social security liabilities, has been completed in respect of the awards vesting on the Grant Date.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jelena Arsic van Os

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) Award of Bonus Shares

Nil

526,435

2) LTIP 2025 award of nil cost options

Nil

778,693

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Sameet Vohra

2.

Reason for the notification

 

 

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

Award of Bonus Shares

Nil

178,853

LTIP 2025 award of nil cost options

Nil

425,432

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFBLFXEQLFBBF
Date   Source Headline
31st Mar 20087:00 amRNSDirector's Interests
28th Mar 20087:01 amRNSDirector's Interests
25th Mar 20087:01 amRNSFull License Agreement
14th Mar 20087:00 amRNSNotifiable Interest
12th Mar 20083:16 pmRNSHolding(s) in Company
11th Mar 20087:00 amRNSNorwegian Agency Agreement
12th Feb 20087:00 amRNSQuarterly Performance Update
31st Jan 20087:01 amRNSTotal Voting Rights
10th Jan 200812:05 pmRNSAdditional Listing
11th Dec 20077:01 amRNSUAE Rights & Expand Capacity
21st Nov 20077:01 amRNSInterim Results
20th Nov 20077:15 amRNSChina License Agreement
20th Nov 20077:01 amRNSNew Business Relationship
15th Oct 20077:00 amRNSLicense Option Agreement
11th Oct 20074:19 pmRNSDirector/PDMR Shareholding
11th Oct 20072:00 pmRNSDirector/PDMR Shareholding
11th Oct 20077:00 amRNSAppointment of new CEO
28th Sep 20077:00 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSDirector's Interests
18th Sep 20077:02 amRNSEuronext Amsterdam Admission
13th Sep 20072:53 pmRNSSUPPLEMENTARY PROSPECTUS
5th Sep 20077:01 amRNSAdditional Listing
4th Sep 20077:02 amRNSProposed Listing
3rd Sep 20077:01 amRNSChina Option Agreement
20th Aug 20077:00 amRNSLISTING ON EURONEXT AMSTERDAM
17th Aug 20077:00 amRNSNew Appointment
16th Aug 20077:00 amRNSHolding(s) in Company
2nd Aug 20076:05 pmRNSTotal Voting Rights
27th Jul 200710:00 amRNSAdditional Listing
28th Jun 20077:01 amRNSPRELIMINARY RESULTS
25th Jun 20077:02 amRNSAgreement
21st Jun 20074:59 pmRNSHolding(s) in Company
4th Jun 20077:01 amRNSHolding(s) in Company
31st May 20077:01 amRNSTotal Voting Rights
24th May 20072:07 pmRNSHolding(s) in Company
23rd May 20079:14 amRNSAppointment
21st May 200711:49 amRNSCompletion of Subscription
16th May 20077:01 amRNSDirectors Options
15th May 20073:19 pmRNSEGM Statement
30th Apr 20072:13 pmRNSTotal Voting Rights
24th Apr 20077:01 amRNSDirector/Notifiable Interests
11th Apr 20077:01 amRNSPosting of circular
2nd Apr 20077:00 amRNSDirector/PDMR Shareholding
28th Mar 20072:18 pmBUSCelanese Corporation Announces Strategic Partnership with Accsys Technologies for Innovative Use of Acetyl Products
28th Mar 20077:04 amRNSStrategic Partnership
19th Mar 20077:02 amRNSProduction commences
6th Feb 20077:00 amRNSHolding(s) in Company
10th Jan 20077:01 amRNSNew Contract
15th Dec 20064:09 pmRNSTotal Voting Rights
13th Dec 200612:52 pmRNSInterim Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.